Clinical Trial Update: A Study to Evaluate the Overall Effects of Treatment With Abbreviated CT-156 in People With Schizophrenia [NA]

View source ↗

Summary

A completed clinical trial evaluating the overall effects of CT-156 in people with schizophrenia. The trial was sponsored by Click Therapeutics, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• CT-156 (CT-156)

Snippet

Sponsor: Click Therapeutics, Inc. | Conditions: Schizophrenia | NA | Status: COMPLETED